During 12-15 years of follow-up, 5.9% of participants developed cardiometabolic multimorbidity (CMM).
- 197 out of 3348 participants developed CMM
- Study population had a mean age of 63 years with 45.1% male
- Participants were free of major cardiometabolic conditions at baseline (2008-2009)
- CMM was defined as having ≥2 of the following: hypertension, cardiovascular disease, diabetes, or stroke
- Follow-up extended to 2021-2023